141 related articles for article (PubMed ID: 32843852)
1. A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts.
Lin J; Yang J; Xu X; Wang Y; Yu M; Zhu Y
Cancer Cell Int; 2020; 20():402. PubMed ID: 32843852
[TBL] [Abstract][Full Text] [Related]
2. [Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
Yang FL; Hong K; Zhao GJ; Liu C; Song YM; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):615-622. PubMed ID: 31420610
[TBL] [Abstract][Full Text] [Related]
3. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
4. Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer.
He Y; Wu Y; Liu Z; Li B; Jiang N; Xu P; Xu A
Front Genet; 2021; 12():694777. PubMed ID: 34589112
[No Abstract] [Full Text] [Related]
5. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
[TBL] [Abstract][Full Text] [Related]
6. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer.
Li F; Teng H; Liu M; Liu B; Zhang D; Xu Z; Wang Y; Zhou H
Front Oncol; 2020; 10():1302. PubMed ID: 32850407
[TBL] [Abstract][Full Text] [Related]
8. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
9. OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts.
Lin J; Xu X; Li T; Yao J; Yu M; Zhu Y; Sun D
Front Oncol; 2021; 11():650678. PubMed ID: 34868901
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
[TBL] [Abstract][Full Text] [Related]
11. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
13. A signature of 24 aging‑related gene pairs predict overall survival in gastric cancer.
Zhang Y; Yan Y; Ning N; Shen Z; Ye Y
Biomed Eng Online; 2021 Apr; 20(1):35. PubMed ID: 33823856
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer.
Chen X; Jin Y; Gong L; He D; Cheng Y; Xiao M; Zhu Y; Wang Z; Cao K
Front Genet; 2020; 11():607. PubMed ID: 32655621
[TBL] [Abstract][Full Text] [Related]
15. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
16. An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma.
Zhu R; Yang X; Guo W; Xu XJ; Zhu L
PeerJ; 2019; 7():e7836. PubMed ID: 31660264
[TBL] [Abstract][Full Text] [Related]
17. Construction and verification of a prognostic risk model based on immunogenomic landscape analysis of bladder caner.
Zhang Y; Xie Y; Feng Y; Wang Y; Xu X; Zhu S; Xu F; Feng N
Gene; 2022 Jan; 808():145966. PubMed ID: 34530089
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
19. Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer.
Liu J; Ma H; Meng L; Liu X; Lv Z; Zhang Y; Wang J
Front Mol Biosci; 2021; 8():675651. PubMed ID: 34095228
[No Abstract] [Full Text] [Related]
20. Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.
Liu B; Fu T; He P; Du C; Xu K
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34143198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
